Related Experiment Video
Updated: Apr 26, 2026
Assessment and Evaluation of the High Risk Neonate: The NICU Network Neurobehavioral Scale
Published on: August 25, 2014
Postnatal environment differentially modulates neurodevelopmental outcomes following voluntary prenatal oxycodone
Kelsea R Gildawie1, Kerri E Budge2, Sara B Isgate2
1Department of Comparative Pathobiology, Cummings School of Veterinary Medicine, Tufts University, North Grafton, MA, USA; Department of Psychology, Simmons University, Boston, MA, USA.
Insights
Prenatal opioid exposure can impact neurodevelopment, but some effects, like altered vocalizations, may improve with a nurturing postnatal environment. However, increased motor activity may persist, indicating a need for early assessment and intervention strategies.
Area of Science:
- Neuroscience
- Developmental Psychology
- Pharmacology
Background:
- Prenatal opioid exposure is a growing concern with complex neurodevelopmental consequences.
- Distinguishing drug effects from postnatal environmental influences is challenging in clinical settings.
- Preclinical models offer a controlled approach to investigate these interactions.
Purpose of the Study:
- To investigate the impact of the postnatal rearing environment on neurodevelopmental outcomes following prenatal oxycodone exposure in a rat model.
- To determine if cross-fostering can ameliorate neonatal opioid withdrawal syndrome (NOWS)-like symptoms.
- To explore the relationship between early behavioral alterations and later physiological changes.
Main Methods:
- Utilized a rat model with voluntary maternal oxycodone self-administration.
- Employed cross-fostering to separate prenatal drug exposure from postnatal rearing conditions.
- Assessed ultrasonic vocalizations, motor activity, and adult physiological markers (corticosterone, MeCP2 expression).
Main Results:
- Altered ultrasonic vocalizations in offspring exposed to oxycodone prenatally were rescued by rearing with drug-naïve dams.
- Increased motor activity persisted irrespective of the postnatal rearing environment.
- Offspring reared by exposed dams exhibited distinct vocalization patterns with lasting effects.
- Maternal opioid intake did not correlate with symptom severity, but early vocalizations predicted adult markers.
Conclusions:
- The postnatal environment can ameliorate some, but not all, neurodevelopmental effects of prenatal opioid exposure.
- Early behavioral assessments, particularly vocalization patterns, may identify offspring at risk for persistent alterations.
- Findings underscore the importance of early intervention and supportive postnatal care for affected offspring.
Abstract:
As prenatal opioid exposure becomes increasingly prevalent, understanding which neurodevelopmental effects are amenable to postnatal intervention has become a critical question. Clinically, prenatal exposure and maternal factors that affect offspring development often co-occur, making it difficult to determine which developmental outcomes are directly attributable to drug effects versus postnatal environmental influences. Preclinical models can be useful in disentangling these interacting factors. Using a rat model of voluntary maternal Oxycodone (Oxy) self-administration, we examined whether postnatal rearing environment could ameliorate neonatal opioid withdrawal syndrome (NOWS)-like symptoms. Cross-fostering separated prenatal drug effects from postnatal rearing and revealed differential sensitivity to environmental modification. Altered ultrasonic vocalizations were rescued when Oxy-exposed offspring were reared by drug-naïve dams, while increased motor activity persisted regardless of rearing condition. Oxy-exposed offspring reared by Oxy-exposed dams showed a distinct developmental trajectory characterized by increased vocal power and reduced frequency variability. These early alterations persisted across the postnatal period. Unexpectedly, maternal opioid intake levels during pregnancy did not predict NOWS-like symptom severity. However, early vocalization patterns did show group-specific predictive relationships with adult markers (plasma corticosterone and nucleus accumbens MeCP2 expression), suggesting potential continuity between early behavioral alterations and later physiological changes. The functional significance of these relationships requires further investigation. Overall, some, but not all, developmental effects of prenatal opioid exposure could be ameliorated by the postnatal rearing environment. These findings suggest that early behavioral profiles may help identify offspring at greatest risk for persistent developmental alterations, highlighting the potential value of early assessment and postnatal intervention.
